BioLizard, a bioinformatics and AI solutions company, announced the appointment of Per Rigler, PhD, as Business Development Manager to spearhead continued growth in Switzerland. Dr Rigler is based in the “Stellwerk”, close to multiple global pharma and chemical companies.
“We are very pleased to have Per join the BioLizard team and expand on our presence in Switzerland,” said Liesbeth Ceelen, Director of Business Development at BioLizard. “As a provider of bioinformatic and AI solutions to the pharmaceutical industry, Switzerland has always been a key market. We have completed multiple projects in support of the world leading research conducted by Swiss based scientists, and with Per’s support, we look forward to many more!”
Dr Rigler joins BioLizard with more than a decade’s experience in the Swiss biotech industry, including extensive experience in bioinformatics, AI and data analysis. He previously worked at Genedata, Carl Zeiss and is a Board member of Gnothis AG, a Swiss biotech company that has pioneered the area of single molecule sequencing and gene analysis. He earned his PhD in physical chemistry and biophysics from Ecole Polytechnique Fédérale de Lausanne (EPFL).
BioLizard NV leverages its expertise in bioinformatics, biostatistics, machine learning, artificial intelligence and data mining to solve the most challenging questions in biology and deliver solutions to clients. By combining expertise from diverse backgrounds, BioLizard provides a complete solution to its client - from data analysis to the system integration and the development of an AI-aided interpretation system. The company was founded by Novalis Biotech Incubation. For more information visit www.lizard.bio.